Manandhar, N. R.; Kayashta, G. K.; Acharya, P. K. Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study. J Patan Acad Health Sci 2018, 5, 47-56.